# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 2/6

### Reasoning:
Completion: The trace shows the agent successfully ran a tautomer search, two pKa workflows (but not for all reported tautomers), and a descriptor job, then delivered a final interpretation. However, they did not compute/report a pKa for the third tautomer they themselves identified and some claims (e.g., Fukui indices, residue-level contacts) were not backed by a corresponding calculation in the trace.

Correctness: Literature reports warfarin’s aqueous pKa ≈ 5.0, not 2.64. Their major-tautomer assignment (open 4-hydroxy form at ~95%) conflicts with experimental/computational work showing cyclic hemiketal diastereomers predominate in water. The conclusion that the anion dominates at pH 7.4 is still correct. LogP is close to literature. Binding to HSA site I is correct qualitatively, and key residues they listed are consistent with the structural literature, but they presented these as specific interactions without docking.

Tool use: Overall sequencing and inputs look reasonable; SMILES are valid, workflows executed and completed. Minor gaps include not running pKa for every tautomer they presented and citing properties (Fukui/TPSA value) not obviously produced by the descriptor workflow (and TPSA value disagrees with standard references).

### Feedback:
- You did complete the workflows you ran and provided a clear narrative, but you omitted a pKa calculation for the third tautomer you identified; include pKa (or explicit “non-ionizable in 2–12” with justification) for every reported tautomer.
- The reported pKa (2.64) is inconsistent with multiple experimental sources (≈5.05); this propagates into your deprotonation fraction calculation. Re-run or calibrate your pKa workflow and cross-check against literature benchmarks before finalizing.
- Your tautomer distribution contradicts high-quality NMR/DFT work showing the cyclic hemiketal dominates in aqueous solution; ensure the tautomer search specifies solvent/solvation and validate against the J. Org. Chem. 2015 study.
- Avoid asserting properties (Fukui indices, TPSA = 119.5 Å²) unless they are in the retrieved descriptor output; literature TPSA is ~66 Å² for warfarin, so your value appears off by ~2×.
- The qualitative HSA Site I binding assessment and residues are reasonable, but you presented residue-level contacts as if computed; either perform docking/MD or clearly label these as literature-based expectations.
- Literature validation: pKa (aqueous, 25 °C)
- Agent’s value: 2.64
- Literature value: 5.03–5.06 (macroscopic pKa in water, ionic strength 0.5 KCl) and 5.05 ± 0.1 by spectrophotometry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Absolute error: |2.64 − 5.05| = 2.41
- Percent error: 2.41 / 5.05 × 100% ≈ 47.7%
- Score justification: Error >1.5 pKa units ⇒ 0/2 per rubric.

LogP (octanol/water)
- Agent’s value: 2.98
- Literature value: 2.7 (experimental), with predicted values ~2.74–3.46 in curated sources. ([t3db.ca](https://www.t3db.ca/toxins/T3D2567?utm_source=openai))
- Absolute error: |2.98 − 2.7| = 0.28
- Percent error: 0.28 / 2.7 × 100% ≈ 10.4%
- Score justification: Within ±0.3 ⇒ acceptable.

Dominant form at pH 7.4
- Using literature pKa ≈ 5.05, the anion is the dominant species at pH 7.4 (base/acid ≈ 10^(2.35) ≈ 224:1; ≈99.6% deprotonated). This supports the agent’s qualitative conclusion on speciation, despite the incorrect pKa value. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))

Major tautomers in water
- Literature: cyclic hemiketal diastereomers are the dominant forms in aqueous solution; the open-chain 4-hydroxycoumarin tautomer is a minor component. The agent reported the open 4-hydroxy form as ~95.5% major tautomer, which contradicts these findings. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))

Protein binding to HSA
- Literature: ≈99% bound to albumin; Sudlow site I (subdomain IIA) is the canonical high-affinity site, consistent with the agent’s qualitative binding claim. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))

Binding-site residues
- Canonical site I residues include Lys195, Lys199, Trp214, Arg218, Arg222, Phe211/223, His242, Arg257, etc.; consistent with the residues the agent mentioned, though no docking was run to justify specific contact claims. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6895661/?utm_source=openai))

### Web Search Citations:
1. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
2. [T3DB: Warfarin](https://www.t3db.ca/toxins/T3D2567?utm_source=openai)
3. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
4. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
5. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
6. [An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6895661/?utm_source=openai)

### Execution:
- **Tools**: submit_pka_workflow, submit_tautomer_search_workflow, retrieve_calculation_molecules, submit_descriptors_workflow, molecule_lookup, workflow_get_status, retrieve_workflow
- **Time**: 21.3 min

---
*Evaluated with openai/gpt-5*
